PRGO

#2154
PERRIGO COMPANY PLC
11.4200 USD
-0.39%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
11.3250
11.4850
Yıllık Aralık
9.2250
22.0100
Günlük Değişim
-0.39%
Aylık Değişim
+15.59%
6 Aylık Değişim
-46.93%
Yıllık Değişim
-46.93%
Önceki Kapanış
11.4650
Açılış
11.4850
Bid
Ask
Düşük
11.3250
High
11.4850
Hacim
1 336
Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler Temettüler
Çeyreklik Yıllık
  • Market Capitalization 1.572 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry İlaç Üreticileri - Özel ve Eşdeğer
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Total debt
Free cash flow
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.35
Price to sales ratio
0.45
Hisse başına temettü
1.16
Temettü getirisi %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Haberler